Hao Liu
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Oncology top 2%
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
Papers in
-
- MicroRNA in disease regulation 25
- Cancer-related molecular mechanisms research 15
-
- Spine and Intervertebral Disc Pathology 10
- Co-authors
- Guoxin Li (28 shared papers)Jiang Yu (18 shared papers)Steven H. Graham (10 shared papers)Xiaolong Qi (12 shared papers)Tingyu Mou (7 shared papers)Zhiyong Shen (6 shared papers)Liying Zhao (9 shared papers)邓海军 (8 shared papers)
- Journals
- Oncotarget (8 papers)PLoS ONE (7 papers)Medicine (5 papers)Proceedings of the National Academy of Sciences (4 papers)Oncology Reports (4 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Hao Liu
316 papers receiving 8.6k citations
Hao Liu's Hit Papers
Peers
Comparison fields: 5 of 148
- Cancer Research 1.8k
- Oncology 1.7k
- Molecular Biology 3.2k
- Pulmonary and Respiratory Medicine 1.1k
- Immunology 725
Countries citing papers authored by Hao Liu
This map shows the geographic impact of Hao Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Liu more than expected).
Fields of papers citing papers by Hao Liu
This network shows the impact of papers produced by Hao Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Liu. The network helps show where Hao Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Hao Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 324 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy Hit paper breakdown → | 2016 | 364 |
| 2 | 2016 | 354 | |
| 3 | 2017 | 237 | |
| 4 | 2016 | 218 | |
| 5 | Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer Hit paper breakdown → | 2022 | 185 |
| 6 | 2020 | 175 | |
| 7 | 2021 | 171 | |
| 8 | 2003 | 153 | |
| 9 | 2020 | 146 | |
| 10 | 2011 | 141 | |
| 11 | 2016 | 137 | |
| 12 | 2015 | 127 | |
| 13 | 2014 | 118 | |
| 14 | 2007 | 116 | |
| 15 | 2013 | 102 | |
| 16 | 2019 | 94 | |
| 17 | 2021 | 94 | |
| 18 | 2020 | 91 | |
| 19 | 2016 | 83 | |
| 20 | 2014 | 82 |
About Hao Liu
Hao Liu is a scholar working on Cancer Research, Pathology and Forensic Medicine, Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 324 papers that have together received 8.7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (25 papers), Cancer-related molecular mechanisms research (15 papers), Autophagy in Disease and Therapy (13 papers), Lung Cancer Treatments and Mutations (13 papers), Gastric Cancer Management and Outcomes (12 papers), RNA modifications and cancer (12 papers), Circular RNAs in diseases (11 papers) and Spine and Intervertebral Disc Pathology (10 papers). The work is most often cited by research in Cancer Research (1.8k citations), Oncology (1.7k citations), Molecular Biology (3.2k citations), Pulmonary and Respiratory Medicine (1.1k citations) and Immunology (725 citations). Hao Liu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Guoxin Li, Jiang Yu, Steven H. Graham, Xiaolong Qi, Tingyu Mou, Zhiyong Shen, Liying Zhao, 邓海军, Yan Zhang and Wende Li. Their work appears in journals such as Oncotarget, PLoS ONE, Medicine, Proceedings of the National Academy of Sciences and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.